Tag Archives: April 25

Public Comment at FDA Stakeholder Meeting, April 25, 2013

My name is Jeannette B. I am paying for my own expenses for being here for this meeting. I am here to urge the FDA to play a more proactive role in working with Hemispherx towards the accelerated approval of … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , | 6 Comments